China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the stock.

China Pharma Trading Up 11.2 %

Shares of CPHI stock opened at $0.20 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The company has a 50 day moving average price of $0.20 and a 200 day moving average price of $0.22. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.60.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.